Phase 3 Aged Clinical Trials
8 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–8 of 8 trials
Recruiting
Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals1,400 enrolled118 locationsNCT02445222
Completed
Phase 3Phase 4
Intravitreal dexamethasone for resistant wet-AMD
Wet aged macular degenerationResistent choroidal neovascularization
A.O.U. Sassari20 enrolled1 locationACTRN12618001102268
Not Yet Recruiting
Phase 3
The Role of Oseltamivir During Influenza Outbreaks in Aged-care Facilities in the Context of Optimal Influenza Vaccination and Infection Control
Influenza in Residential Aged Care FacilitiesSurveillance systems for influenza in Residential Aged Care Facilities
Children's Hospital, Westmead: National Centre for Immunisation Research and Surveillance74 enrolled1 locationACTRN12615000638538
Recruiting
Phase 3
Evaluating the Utility of a Patient Decision Aid for Prospective Participants in the Trans-Tasman Radiation Oncology Group Radiotherapy - Adjuvant Versus Early Salvage Prostate Cancer Trial
Decision-making for clinical trial participation in men with prostate cancer who have positive margins and/or pathologic stage T3 (pT3; cancer extending beyond the capsule of the prostate gland) disease following radical prostatectomy, aged over 18 years.
Psycho-Oncology Cooperative Research Group (PoCoG)150 enrolled2 locationsACTRN12611001024932
Completed
Phase 3Phase 4
Azithromycin versus Amoxicillin for Treatment of Acute otitis media in Aboriginal Children (AATAAC)
Acute otitis media in Indigenous children aged 6 months to 6 years
NHMRC330 enrolled1 locationACTRN12609000691246
Completed
Phase 3
A randomised, double blind, placebo controlled trial of the effectiveness of “post donation” short term iron replacement in female whole blood donors with a daily oral dose of 45 mgs elemental iron
Iron deficiency in female blood donors aged 18-45 years
Australian Red Cross Blood Service260 enrolled1 locationACTRN12609000496213
Completed
Phase 2Phase 3
The acceptability, safety and tolerability of combined methadone-naloxone in methadone maintained individuals aged between 18 - 65
Participants are opiod dependant and methadone maintained individuals aged between 18-65
Langton Centre10 enrolled1 locationACTRN12608000024347
Recruiting
Phase 3Phase 4
Testosterone in Obese Men Trial
Testosterone deficiency in ageing malesObese Middle-Aged and Older Men with Borderline Androgen Deficiency
PHIMR40 enrolled1 locationACTRN12605000283673